TherapeuticsMD TXMD
NASDAQ TXMD
$1.85 -0.05 (-2.63%)
At close: Oct 22, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Depreciation & Amortization (CF) (2010 - 2026)

Updated

TherapeuticsMD (TXMD) reported Depreciation & Amortization (CF) of $95,000 for Q2 2026, down 1.0% from $96,000 a year earlier but up 1.1% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, TherapeuticsMD's Depreciation & Amortization (CF) came in at $382,000, down 1.3% year-over-year; for FY2025, it was $384,000, down 24.6% from FY2024.

  • Depreciation & Amortization (CF) has declined for three consecutive years, with a five-year compound annual growth rate of -37.6% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $509,000 in FY2024 (-44.8%), $922,000 in FY2023 (-22.7%), $1.19 million in FY2022 (+62.1%) and $736,000 in FY2021 (-81.9%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of -$2.36 million in Q4 2021 and a high of $1.03 million in Q3 2021.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last three quarters, with an average decline of 23.8% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2024 (growth of 392.6%); the low point was Q1 2023 (a decline of 91.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $94,000 (Q1 2026), $97,000 (Q4 2025) and $96,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 TherapeuticsMD 21.59 Mn 21.59 Mn - 95,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95,000.00
Mar 31, 2026 94,000.00
Dec 31, 2025 97,000.00
Sep 30, 2025 96,000.00
Jun 30, 2025 96,000.00
Mar 31, 2025 95,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 96,000.00
Jun 30, 2024 180,000.00
Mar 31, 2024 133,000.00
Dec 31, 2023 637,000.00
Sep 30, 2023 130,000.00
Jun 30, 2023 129,000.00
Mar 31, 2023 27,000.00
Dec 31, 2022 309,000.00
Sep 30, 2022 273,000.00
Jun 30, 2022 282,000.00
Mar 31, 2022 329,000.00
Dec 31, 2021 -2.36 Mn
Sep 30, 2021 1.03 Mn
API Access

TherapeuticsMD Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TXMD&period=max&api_key=YOUR_API_KEY